Area of research
Endocrinology, Diabetes and Metabolism · Surgery
Research interest
Research interests include Pituitary Gland Disorders and Treatments, Growth Hormone and Insulin-like Growth Factors, Adrenal Hormones and Disorders, and Adrenal and Paraganglionic Tumors.
Osilodrostat-associated Adrenal Gland Shrinkage: A Case Series of Patients With ACTH-dependent Cushing's Syndrome.
Efficacy and Safety of Once-Weekly Lonapegsomatropin in Adults With Growth Hormone Deficiency: foresiGHt Trial Results.
Rapid and Sustained Response of Biochemically Uncontrolled Acromegaly to Once-daily Oral Paltusotine Treatment.
Impact of sex on mortality in patients with pituitary adenomas.
Acromegaly Complications: An Update.
A Novel Evaluation of 24-hour Energy Metabolism in Cushing's Syndrome: The Metabolic Cost of Hypercortisolism.
Approach to the Patient with Cushing's Syndrome: Use of Anticoagulation Therapy.
Consensus on acromegaly complications: an update.
Consensus on acromegaly complications: an update
Consensus on acromegaly therapeutic outcomes: an update
Consensus on acromegaly therapeutic outcomes: an update.
Pituitary incidentaloma: a Pituitary Society international consensus guideline statement.
Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies
Osilodrostat Treatment of Cushing Syndrome in Real-World Clinical Practice: Findings From the ILLUSTRATE study
Delphi panel consensus on recommendations for thromboprophylaxis of venous thromboembolism in endogenous Cushing's syndrome: a position statement.
Osilodrostat Treatment of Cushing Syndrome in Real-World Clinical Practice: Findings From the ILLUSTRATE study.
Identifying research priorities for pituitary adenoma surgery: an international Delphi consensus statement
Mortality in Cushing's syndrome: declining over 2 decades but remaining higher than the general population.
Prolactin-secreting adenomas: pathogenesis, diagnosis, and management.
Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study
Osilodrostat Treatment for Adrenal and Ectopic Cushing Syndrome: Integration of Clinical Studies With Case Presentations.
Osilodrostat dose impact on efficacy/safety in Cushing's disease: large, pooled analysis of LINC 2, 3, and 4.
Impact of pasireotide on lipid and glucose metabolism in patients with acromegaly: a systematic review and meta-analysis.
PANOMEN-3 grading score is reliable in predicting pituitary adenoma behavior and prognosis: a single center cohort study.
Weight gain reversibility and BMI following treatment for Cushing's syndrome: long-term outcomes and potential predictors.
Leukocytosis in Cushing's syndrome persists post-surgical remission and could predict a lower remission prognosis in patients with Cushing's disease.
Hypercoagulability in Cushing's syndrome: past, present, future.
Development of a Minimum Dataset for the Global Monitoring of the Safety and Efficacy of Growth Hormone Replacement in Adults With Growth Hormone Deficiency (AGHD).
Predictors of cancer in patients with endogenous Cushing's syndrome.
Impact of remission status in endogenous Cushing's syndrome on cancer incidence.